ORBi: Detailled Reference

Article (Scientific journals)

HEREDITARY LEIOMYOMATOSIS AND ACUTE LYMPHOBLASTIC LEUKEMIA: a LINK THROUGH FUMARATE DYSHYDRATASE MUTATION?

Bailleux, Sophie; SOMJA, Joan; MARTIN, Marie et al.

2022 • In Acta Clinica Belgica, 77, p. 778-781

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/263999

DOI
10.1080/17843286.2021.1980669

PubMed
34515613

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Hereditary leiomyomatosis and acute lymphoblastic leukemia A link through fumarate dyshydratase mutation(1).pdf

Author postprint (1.33 MB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Hereditary leiomyomatosis; T-cell acute lymphoblastic leukemia; T-All; fumarate hydratase; mutation

Abstract :

[en] Background: Hereditary leiomyomatosis (HL) is an autosomal dominant condition due to a variety of fumarate hydratase (FH) mutations in which individuals tend to develop cutaneous leiomyomas, multiple uterine leiomyomas and are at risk for developing aggressive papillary renal cell carcinoma. Case presentation: A 26-year-old man with a past history of acute lymphoblastic leukemia (T-ALL) presented with numerous painful light brown papules and nodules spread all over his body except for the head, appearing since infancy. Similar lesions were present in his mother’s family. A cutaneous biopsy revealed a cutaneous leiomyoma. His mother died from metastatic uterine neoplasia and his sister suffered from leiomyoma of the uterus. No renal cancer was reported in his family. A heterozygous pathogenic variant was detected in the FH gene. Conclusion: To our knowledge, this is the first case possibly linking HL and T-ALL through FH deficiency.

Disciplines :

Dermatology

Author, co-author :

Bailleux, Sophie ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service de dermatologie

SOMJA, Joan ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Service d'anatomie et cytologie pathologiques

MARTIN, Marie ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Consultation Génétique

DE PRIJCK, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'hématologie clinique

NIKKELS, Arjen ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service de dermatologie

Language :

English

Title :

HEREDITARY LEIOMYOMATOSIS AND ACUTE LYMPHOBLASTIC LEUKEMIA: a LINK THROUGH FUMARATE DYSHYDRATASE MUTATION?

Publication date :

2022

Journal title :

Acta Clinica Belgica

ISSN :

1784-3286

eISSN :

2295-3337

Publisher :

Taylor and Francis, Abingdon, United Kingdom

Volume :

77

Pages :

778-781

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 04 October 2021

Statistics

Number of views

98 (7 by ULiège)

Number of downloads

100 (3 by ULiège)

More statistics

Scopus citations^®

0

Scopus citations^®
without self-citations

0

OpenCitations

0

Bibliography

Launonen V, Vierimaa O, Kiuru M, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A. 2001; 98 (6): 3387–3392.
Menko FH, Maher ER, Schmidt LS, et al. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer. 2014; 13 (4): 637–644.
Gardie B, Remenieras A, Kattygnarath D, et al. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet. 2011; 48 (4): 74–80.
Arenas VC, Rodríguez LML, Cardona BAY, et al. Hereditary leiomyomatosis and renal cell cancer syndrome: identification and clinical characterization of a novel mutation in the FH gene in a Colombian family. Fam Cancer. 2017; 16 (1): 117–122.
Alam NA, Bevan S, Churchman M, et al. Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. Am J Hum Genet. 2001; 68 (5): 1264–1269.
Alam N, Barclay E, Rowan AJ, et al. Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome. Arch Dermatol. 2005; 141 (2): 199–206.
Smit DL, Mensenkamp AR, Badeloe S, et al. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet. 2011; 79 (1): 49–59.
Jabbour E, O’Brien S, Konopleva M, et al. New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer. 2015; 121: 2517–2528.
Liu Y, Easton J, Shao Y, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017; 49 (8): 1211–1218.
Medinger M, Heim D, Lengerke C, et al. Akute Lymphoblastische Leukämie–diagnostik und Therapie. Ther Umsch. 2019; 76 (9): 510–515.
Beldjord K, Chevret S, Asnafi V, et al. Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL). Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood. 2014; 123 (24): 3739–3749.
MH W, Toure O, Gm G, et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. 2005; 43 (1): 18–27.
Gironi L, Pasini B, Farinelli P, et al. Hereditary leiomyomatosis and renal cell cancer: do you know this syndrome? J Pathol Micro. 2016; 1. 1–3.
Toro JR, Nickerson ML, Wei MH, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003; 73 (1): 95–106.
Pithukpakorn M, et al. Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. 2006; 43 (9): 755–762.
Sanz-Ortega J, Vocke C, Stratton P, et al. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol. 2013; 37 (1): 74–80.
Patel VM, Handler MZ, Schwartz RA, et al. Hereditary leiomyomatosis and renal cell cancer syndrome: an update and review. J Am Acad Dermatol. 2017; 77 (1): 149–158.
Muller M, Ferlicot S, Guillaud-Bataille M, et al. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers. Clin Genet. 2017; 92 (6): 606–615.
Weiler L, Poulalhon N, Slama A, et al. Isolated cutaneous leiomyosarcoma revealing a novel germline mutation of fumarate hydratase gene. Br J Dermatol. 2016; 175 (5): 1104–1106.
Apatenko AK, Turusov VS. The painful tumours of the skin. Neoplasma. 1968; 15: 187–202.
Garman ME, Blumberg MA, Ernst R, et al. Familial leiomyomatosis: a review and discussion of pathogenesis. Dermatology. 2003; 207 (2): 210–213.
Emer JJ, Solomon S, Mercer SE. Reed’s syndrome: a case of multiple cutaneous and uterine leiomyomas. J Clin Aesthet Dermatol. 2011; 4: 37–42.
Wang C, Tetzlaff M, Hick R, et al. Reed syndrome presenting with leiomyosarcoma. JAAD Case Rep. 2015; 1 (3): 150–152.
Schmidt LS, Linehan WM. Hereditary leiomyomatosis and renal cell carcinoma. International Journal of Nephrology and Renovascular Disease. 2014; 7: 253–260.
Ekanem E, Talaulikar V. Medical therapy for fibroids: what next for ulipristal acetate? Adv Ther. 2021; 202 (38): 137–148
Alam NA, Olpin S, Leigh IM. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol. 2005; 153 (1): 11–17.
Basendwh MA, Fatani M, Baltow B. Reed’s Syndrome: a Case of Multiple Cutaneous Leiomyomas Treated with Liquid Nitrogen Cryotherapy. Case Rep Dermatol. 2016; 8 (1): 65–70.
Hansen AW, Chayed Z, Pallesen K, et al. Hereditary Leiomyomatosis and Renal Cell Cancer. Acta Derm Venereol. 2020; 100. DOI: 10.2340/00015555-3366.
Malik K, Patel P, Chen J, et al. Leiomyoma cutis: a focused review on presentation, management, and association with malignancy. Am J Clin Dermatol. 2015; 16 (1): 35–46.
Tomlinson IP, Alam NA, Rowan AJ, et al. Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002; 30: 406–410.
Bayley JP, Launonen V, Tomlinson IP. The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet. 2008; 25 (1): 20.
Linehan WM, Rouault TA. Molecular Pathways: fumarate Hydratase -Deficient Kidney Cancer—Targeting the Warburg Effect in Cancer. Clin Cancer Res. 2013; 19 (13): 150–152.
Schmidt C, Sciacovelli M, Frezza C. Fumarate hydratase in cancer: a multifaceted tumour suppressor. Semin Cell Dev Biol. 2020; 98: 15–25.
Ha Y-S, Chihara Y, Yoon H-Y, et al. Downregulation of fumarate hydratase Is related to tumorigenesis in sporadic renal cell cancer. Urol Int. 2013; 90 (2): 233–239.
Zhang J, Walsh MF, Wu G, et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med. 2015; 373 (24): 2336–2346.
Fieuw A, Kumps C, Schramm A, et al. Identification of a novel recurrent 1q42.2-1qter deletion. in Schmidt et al. Page 14 Semin Cell Dev Biol. Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts high risk MYCN single copy 11q deleted neuroblastomas. Int J Cancer. 2011; 130 (11): 2599–2606.
Castro-Vega LJ, Buffet A, De Cubas AA, et al. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet. 2014; 23: 2440–2446.
Hu J, Locasale JW, Bielas JH, et al. Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat Biotechnol. 2013; 31 (6): 522.
Frezza C, Pollard PJ, Gottlieb E. Inborn and acquired metabolic defects in cancer. J Mol Med. 2011; 89 (3): 213–220.
Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK, et al. Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet. 2006; 43 (6): 523–526.
Guitart AV, Panagopoulou TI, Villacreces A, et al. Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions. J Exp Med. 2017; 214 (3): 719–735.

Similar publications